Scientists in the UK have recruited the world’s first participants as part of a new long-acting antibody study. If the treatment is effective, it may protect those who have already been exposed to SARS-CoV-2 from the development of COVID-19. “We know that this antibody mixture can inactivate the virus,” explains …
Read More »A new treatment to protect people with stork-cove-2 from the tests that start sick now
